13F filing recap · Q1 2026
What did ARK Invest buy in Q1 2026?
Reported stock-position changes between this filing and the previous one. US-listed stocks across every ARK-managed account, including accounts that belong to no fund below.
Stock value
$12.86B
Positions
180
Estimated turnover
20.9%
Turnover is a proxy: verified trade-origin share changes valued at period-end and divided by average reported stock value. SEC holdings reports do not disclose execution dates or prices. Corporate actions and unreconciled activity are excluded.
Quarter in review
ARK Invest opened new positions in Broadcom, Eli Lilly, Biontech, Generate Biomedicines, Paypay, and several smaller names. It exited Amgen, DuPont, Eastman Chemical, Exact Sciences, PayPal, Qualcomm, Regeneron, Trade Desk, Unity Software, Veeva Systems, Vertex Pharmaceuticals, and others. Among existing holdings, it trimmed Teradyne, Roku, Meta Platforms, Iridium Communications, and DraftKings, while adding to Genedx Holdings, Figma, Joby Aviation, Caterpillar, Intuitive Surgical, Weride, and Kodiak Ai.